Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Minerva Neurosciences - 11 Year Stock Price History | NERV

Historical daily share price chart and data for Minerva Neurosciences since 2014 adjusted for splits and dividends. The latest closing stock price for Minerva Neurosciences as of May 08, 2025 is 1.61.
  • The all-time high Minerva Neurosciences stock closing price was 117.60 on May 26, 2020.
  • The Minerva Neurosciences 52-week high stock price is 3.69, which is 129.2% above the current share price.
  • The Minerva Neurosciences 52-week low stock price is 1.15, which is 28.6% below the current share price.
  • The average Minerva Neurosciences stock price for the last 52 weeks is 2.40.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Minerva Neurosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.8535 2.3000 2.6800 1.3400 1.6100 -27.53%
2024 3.5008 6.1500 12.4700 2.1000 2.2216 -63.88%
2023 5.5195 1.5100 13.0500 1.5100 6.1500 286.79%
2022 5.1200 7.3592 13.4300 1.4300 1.5900 -75.19%
2021 17.6405 19.0400 28.7200 6.4080 6.4080 -65.77%
2020 42.6013 61.1200 117.6000 18.0800 18.7200 -67.09%
2019 52.6430 55.3600 69.2800 32.6400 56.8800 5.49%
2018 64.3960 49.6000 100.4000 40.4000 53.9200 11.40%
2017 62.2709 94.0000 98.8000 39.6000 48.4000 -48.51%
2016 76.6441 47.0400 115.0400 28.3200 94.0000 93.57%
2015 42.9533 48.8800 51.9200 34.7200 48.5600 0.83%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.011B $0.000B
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $96.855B 36.33
Zoetis (ZTS) United States $69.448B 25.91
Daiichi Sankyo, - (DSNKY) Japan $48.042B 24.44
Takeda Pharmaceutical (TAK) Japan $47.919B 10.61
Sandoz Group AG (SDZNY) Switzerland $19.518B 0.00
Summit Therapeutics (SMMT) United States $18.039B 0.00
Merck (MKKGY) Germany $17.790B 14.72
Shionogi (SGIOY) Japan $13.871B 13.90
United Therapeutics (UTHR) United States $13.844B 12.25
Neurocrine Biosciences (NBIX) United States $12.035B 41.22
IPSEN (IPSEY) France $10.376B 0.00
Orion OYJ (ORINY) Finland $9.160B 24.77
Corcept Therapeutics (CORT) United States $7.472B 60.74
Madrigal Pharmaceuticals (MDGL) United States $6.635B 0.00
Stevanato Group S.p.A (STVN) Italy $6.602B 41.92
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.263B 0.00
Grifols, S.A (GRFS) Spain $5.033B 0.00
Soleno Therapeutics (SLNO) United States $3.726B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.939B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.861B 10.03
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.238B 12.24
BioCryst Pharmaceuticals (BCRX) United States $2.109B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.078B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.684B 0.00
Guardian Pharmacy Services (GRDN) United States $1.635B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.613B 0.00
Indivior (INDV) United States $1.583B 6.71
Evotec AG (EVO) Germany $1.481B 0.00
ARS Pharmaceuticals (SPRY) United States $1.325B 168.62
Ocular Therapeutix (OCUL) United States $1.123B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.108B 45.06
Dyne Therapeutics (DYN) United States $1.068B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.915B 0.00
Harrow (HROW) United States $0.902B 0.00
Enliven Therapeutics (ELVN) United States $0.896B 0.00
Ardelyx (ARDX) United States $0.885B 0.00
Collegium Pharmaceutical (COLL) United States $0.869B 4.62
AleAnna (ANNA) United States $0.716B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.701B 0.00
Organogenesis (ORGO) United States $0.657B 0.00
Akebia Therapeutics (AKBA) United States $0.644B 0.00
KalVista Pharmaceuticals (KALV) United States $0.609B 0.00
Xencor (XNCR) United States $0.568B 0.00
Bioventus (BVS) United States $0.540B 13.73
Savara (SVRA) United States $0.529B 0.00
USANA Health Sciences (USNA) United States $0.529B 11.49
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Relay Therapeutics (RLAY) United States $0.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.500B 0.00
Elite Pharmaceuticals (ELTP) United States $0.448B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.434B 0.00
Altimmune (ALT) United States $0.413B 0.00
Zevra Therapeutics (ZVRA) United States $0.411B 0.00
CytoDyn (CYDY) United States $0.401B 0.00
Tourmaline Bio (TRML) United States $0.395B 0.00
Verve Therapeutics (VERV) United States $0.376B 0.00
Siga Technologies (SIGA) United States $0.375B 6.40
Oruka Therapeutics (ORKA) United States $0.357B 0.00
Heron Therapeutics (HRTX) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 8.92
Aquestive Therapeutics (AQST) United States $0.271B 0.00
Avita Medical (RCEL) United States $0.250B 0.00
Nature's Sunshine Products (NATR) United States $0.243B 22.46
Wellgistics Health (WGRX) United States $0.224B 0.00
MediWound (MDWD) Israel $0.193B 0.00
ProKidney (PROK) United States $0.187B 0.00
OmniAb (OABI) United States $0.187B 0.00
Esperion Therapeutics (ESPR) United States $0.173B 0.00
Journey Medical (DERM) United States $0.161B 0.00
Nanobiotix S.A (NBTX) France $0.156B 0.00
Profound Medical (PROF) Canada $0.145B 0.00
4D Molecular Therapeutics (FDMT) United States $0.144B 0.00
Larimar Therapeutics (LRMR) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Aclaris Therapeutics (ACRS) United States $0.135B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.128B 0.00
Lyell Immunopharma (LYEL) United States $0.124B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Aldeyra Therapeutics (ALDX) United States $0.120B 0.00
Nektar Therapeutics (NKTR) United States $0.113B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
Lexeo Therapeutics (LXEO) United States $0.099B 0.00
Galectin Therapeutics (GALT) United States $0.099B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.089B 0.00
VAXART, INC (VXRT) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Achieve Life Sciences (ACHV) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 13.20
ESSA Pharma (EPIX) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 49.11
Vivani Medical (VANI) United States $0.060B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.034B 0.00
Prelude Therapeutics (PRLD) United States $0.033B 0.00
FibroGen (FGEN) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Surrozen (SRZN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.52
DURECT (DRRX) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.22
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00